Digestome therapeutics inc
WebFeb 27, 2024 · Information on valuation, funding, cap tables, investors, and executives for Digestome Therapeutics. Use the PitchBook Platform to explore the full profile. WebJun 1, 2024 · Digestome Therapeutics was established by Remiges Ventures, based on the ground-breaking research of Dr. Kousaku Ohinata from Kyoto University. Food affects …
Digestome therapeutics inc
Did you know?
WebDigestome Therapeutics is a private biotech company developing first-in-class therapeutics targeting a clinically proven mechanism, VNS (vagus nerve stimulation). VNS has been FDA approved in epilepsy and depression, and is in trials for other psychiatric, neurodegenerative and inflammatory diseases. However, the products are medical … WebMar 8, 2024 · SAN FRANCISCO, March 8, 2024 /PRNewswire/ -- Digestome Therapeutics, a biotech company developing first-in-class therapeutics that stimulate …
WebDigestome Therapeutics is a private biotech company developing first-in-class therapeutics targeting a clinically proven mechanism, VNS (vagus nerve stimulation). VNS has been FDA approved in... WebClients Zhongze Therapeutics (Cayman) Holding Limited. Jones Day represented Zhongze Therapeutics (Cayman) Holding, Ltd. in an exclusive license and collaboration agreement with Digestome Therapeutics, Inc. to develop, manufacture, and commercialize Digestome's first-in-class oral therapeutic ALT-100 in the Greater China territory.
WebDIGESTOME THERAPEUTICS, INC. is a Massachusetts Foreign Corporation filed on January 3, 2024. The company's File Number is listed as 001306399. The Registered Agent on file for this company is Corp2000 and is located at 1900 West Park Dr., Ste. 280b, Westborough, MA 01581. WebPrior to Vincerx, he was active in company creation as President of Digestome Therapeutics and as an advisor to multiple early stage biotechs pioneering first-in-class therapies to address unmet patient needs including T-Cure, Quadriga, and Pellepharm. Earlier, Dr Hwang led business development at Supergen where he closed an epigenetic …
WebFeb 25, 2024 · "Digestome is excited to work with Zhongze Therapeutics to develop DGX-001 for the greater China markets," said Ken Horne, President of Digestome Therapeutics. "Zhongze and Digestome share a ...
WebDIGESTOME THERAPEUTICS, INC is a California Stock Corporation - Out Of State - Stock filed on February 13, 2024. The company's filing status is listed as Active and its File Number is 4566652. The Registered Agent on file for this company is Corp2000 and is located at 720 14th Street, Sacramento, CA 95814. The company's principal address is ... playboy anti social social club shirtWebDigestome Therapeutics is a private biotech company developing first-in-class therapeutics targeting a clinically proven mechanism, VNS (vagus nerve stimulation). VNS has been FDA approved in epilepsy and depression, and is in trials for other psychiatric, neurodegenerative and inflammatory diseases. However, the products are medical … primary care eagle riverWebTherapeutics. Headquarters Regions Asia-Pacific (APAC) Founded Date 2024. Founders Alan Au. Operating Status Active. Last Funding Type Venture - Series Unknown. Company Type For Profit. GT Apeiron Therapeutics is a developer of innovative drugs utilizing artificial intelligence technology. The company develops breakthrough investigational ... primary care eagle river akWebDigestome Therapeutics. Business Services · United States · <25 Employees . Digestome Therapeutics was founded in 2024, is a private biotech company developing first-in-class therapeutics focused on the discovery and development of a new class of drugs that could treat depression, anxiety, gastrointestinal diseases, enabling researchers an d doctors to … primary care east cobbWebAdvanced Brain Monitoring, Inc USA Private Advanced Brain Monitoring, Inc. develops and delivers innovative solutions for sleep apnea diagnosis, memory dysfunction measurement, and alertness monitoring. The company offers B-Alert X4, a compact form factor to maximize ease-of-use and comfort in real-world environments, B-Alert X10 system, a ... primary care ear clinic clarksonWebMar 8, 2024 · SAN FRANCISCO, March 8, 2024 /PRNewswire/ -- Digestome Therapeutics, a biotech company developing first-in-class therapeutics that stimulate … primary care eagle idahoWebDigestome Therapeutics, Inc. ... Atelerix Life Sciences Inc. is a newly-created Delaware C corporation organized to develop and commercialize a novel family of cutting-edge proprietary small ... playboy artist leroy